Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.45 |
| ▸ | CDK4 | P11802 | 1/20 | 0.44 |
| ▸ | CCND1 | P24385 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | GLA | P06280 | 3/20 | 0.39 |
| ▸ | MAOA | P21397 | 2/20 | 0.39 |
| ▸ | CASP1 | P29466 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28537969 | 0.81 | DYRK1A (0.37) | DYRK1AALDH1A1MAPTCYP3A4SMN1; SMN2 | |
| SCHEMBL28540640 | 0.81 | DYRK1A (0.37) | DYRK1ACYP3A4CDK4CCND1 | |
| SCHEMBL356854 | 0.78 | DYRK1A (0.35) | DYRK1AALDH1A1MAPTCYP3A4SMN1; SMN2 | |
| SCHEMBL4503458 | 0.77 | CDK4 (0.43) | DYRK1AALDH1A1MAPTCYP3A4SMN1; SMN2 | |
| SCHEMBL28545983 | 0.77 | ALDH1A1 (0.41) | DYRK1AALDH1A1MAPTCYP3A4SMN1; SMN2 | |
| SCHEMBL249194 | 0.76 | DYRK1A (0.38) | DYRK1AALDH1A1MAPTCYP3A4SMN1; SMN2 | |
| SCHEMBL28547076 | 0.76 | DYRK1A (0.33) | DYRK1ACYP3A4 | |
| SCHEMBL6648490 | 0.75 | DYRK1A (0.52) | DYRK1AALDH1A1MAPTCYP3A4SMN1; SMN2 | |
| SCHEMBL28534158 | 0.75 | CDK4 (0.41) | DYRK1AALDH1A1MAPTCYP3A4SMN1; SMN2 | |
| SCHEMBL249195 | 0.73 | DYRK1A (0.45) | DYRK1AALDH1A1MAPTCYP3A4SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545643-B2 | 3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same | Amenis Bioscience, Inc (KR) | 2026-02-10 | — | — | US | disclosed |
| CN-117651552-A | Therapeutic or prophylactic agent for covd-19 | 国立大学法人广岛大学 | 2024-03-05 | — | — | CN | disclosed |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | HIROSHIMA UNIVERSITY (JP) | 2024-01-25 | — | — | US | disclosed |
| EP-4248997-A1 | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR COVID-19 | Hiroshima University (JP) | 2023-09-27 | — | — | EP | disclosed |
| US-20230133581-A1 | Novel 3,5-Diaminobenzoic Acid Compound, and PIN1 Inhibitor and Therapeutic Agent for Inflammatory Diseases Using Same | HIROSHIMA UNIVERSITY (JP) | 2023-05-04 | — | — | US | disclosed |
| EP-4119165-A1 | NOVEL 3,5-DIAMINOBENZOIC ACID COMPOUND, AND PIN1 INHIBITOR AND THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES USING SAME | Hiroshima University (JP) | 2023-01-18 | — | — | EP | disclosed |
| CN-115397466-A | Novel 3,5-diaminobenzoic acid-based compound, pin1 inhibitor using same, and therapeutic agent for inflammatory disease | 国立大学法人广岛大学 | 2022-11-25 | — | — | CN | disclosed |
| WO-2022107745-A1 | THERAPEUTIC AGENT OR PROPHYLACTIC AGENT FOR COVID-19 | 国立大学法人広島大学 | 2022-05-27 | — | — | WO | disclosed |
| EP-0733649-B1 | Peroxycarboxylic ester photoinitiators derived from nitrogen heterocycles | MINNESOTA MINING & MFG (US) | 2000-07-12 | — | — | EP | disclosed |
| US-5599652-A | PHOTOPOLYMERIZABLE MIXTURES ALSO WITH FREE RADICAL POLYMERIZABLE COMPOUNDS AND PHOTOSENSITIZERS | IMATION CORP. (US) | 1997-02-04 | — | — | US | disclosed |
| EP-0733649-A1 | Peroxycarboxylic ester initiators derived from nitrogen heterocycles | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133581-A1 | Novel 3,5-Diaminobenzoic Acid Compound, and PIN1 Inhibitor and Therapeutic Agent for Inflammatory Diseases Using Same | PIN1, DUSP15, FKBP1A | DYRK1A 746/4885ALDH1A1 2183/4885MAPT 574/4885 |
| US-12545643-B2 | 3,5-diaminobenzoic acid compound, and Pin1 inhibitor and therapeutic agent for inflammatory diseases using same | PIN1, FKBP1A, FKBP2 | DYRK1A 1673/4885ALDH1A1 3496/4885MAPT 835/4885 |
| US-20240024266-A1 | Therapeutic Agent or Prophylactic Agent for COVID-19 | PIN1, ACE2, ACE | DYRK1A 3235/4885ALDH1A1 4006/4885MAPT 261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.